CSTONE PHARMA-B (02616) completes the placement of 100 million shares of placement shares.
Jichishiyao Pharmaceutical-B (02616) announced that all conditions for the placement have been met, and the placement was completed on July 1, 2025.
CSTONE PHARMA-B (02616) announces that all conditions of the placement have been met and the placement was completed on July 16, 2025. According to the terms of the placement agreement, 100 million shares of placement shares have been successfully placed by the placement agent to at least six underwriters at a placement price of HK$4.72 per share.
Related Articles
HK Stock Market Move | NIO-SW (09866) rises by over 7% again, LeDao L90 presale price far exceeds expectations, Morgan Stanley expects monthly sales volume to exceed 5000 vehicles.
Under heavy pressure from high expenses on AI, Amazon.com, Inc. (AMZN.US) is laying off employees in its cloud computing department AWS.
Guotai Haitong: The coal industry is currently at a turning point in its fundamentals. We recommend China Shenhua Energy (601088.SH) and others.
HK Stock Market Move | NIO-SW (09866) rises by over 7% again, LeDao L90 presale price far exceeds expectations, Morgan Stanley expects monthly sales volume to exceed 5000 vehicles.
Under heavy pressure from high expenses on AI, Amazon.com, Inc. (AMZN.US) is laying off employees in its cloud computing department AWS.
Guotai Haitong: The coal industry is currently at a turning point in its fundamentals. We recommend China Shenhua Energy (601088.SH) and others.
RECOMMEND
After Six Months of Global Sales Explosion, Is Pop Mart Facing an Emotional Turning Point?
17/07/2025
EU Unveils 202-Page Countermeasure List Targeting $84 Billion in U.S. Goods, Including Aircraft and Whiskey
17/07/2025
Federal Reserve Beige Book: Tariff Pressures Raising Business Costs, Inflation May Accelerate
17/07/2025
